- Home
- SCNI vs RSLS Comparison
SCNI vs RSLS Comparison
Compare SCNI & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- RSLS
- Stock Information
- Founded
- SCNI 2003
- RSLS 2002
- Country
- SCNI Israel
- RSLS United States
- Employees
- SCNI N/A
- RSLS N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- RSLS Medical/Dental Instruments
- Sector
- SCNI Health Care
- RSLS Health Care
- Exchange
- SCNI Nasdaq
- RSLS Nasdaq
- Market Cap
- SCNI 3.1M
- RSLS 3.2M
- IPO Year
- SCNI N/A
- RSLS 2007
- Fundamental
- Price
- SCNI $3.51
- RSLS $4.52
- Analyst Decision
- SCNI
- RSLS Hold
- Analyst Count
- SCNI 0
- RSLS 1
- Target Price
- SCNI N/A
- RSLS N/A
- AVG Volume (30 Days)
- SCNI 8.1K
- RSLS 21.9K
- Earning Date
- SCNI 11-22-2024
- RSLS 11-14-2024
- Dividend Yield
- SCNI N/A
- RSLS N/A
- EPS Growth
- SCNI N/A
- RSLS N/A
- EPS
- SCNI 8.20
- RSLS N/A
- Revenue
- SCNI $452,000.00
- RSLS $8,183,000.00
- Revenue This Year
- SCNI N/A
- RSLS $17.47
- Revenue Next Year
- SCNI N/A
- RSLS $20.00
- P/E Ratio
- SCNI $0.43
- RSLS N/A
- Revenue Growth
- SCNI N/A
- RSLS N/A
- 52 Week Low
- SCNI $2.23
- RSLS $4.09
- 52 Week High
- SCNI $8.92
- RSLS $29.00
- Technical
- Relative Strength Index (RSI)
- SCNI 52.75
- RSLS 44.77
- Support Level
- SCNI $3.41
- RSLS $4.35
- Resistance Level
- SCNI $3.80
- RSLS $5.19
- Average True Range (ATR)
- SCNI 0.18
- RSLS 0.33
- MACD
- SCNI -0.00
- RSLS 0.04
- Stochastic Oscillator
- SCNI 36.42
- RSLS 21.18
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.